Medicine and Dentistry
Optical Coherence Tomography
100%
Visual Field Test
54%
Gene Therapy
54%
Color Blindness
43%
Retinitis pigmentosa
43%
Stargardt Disease
43%
Equine Infectious Anemia Virus
40%
Best Corrected Visual Acuity
38%
Clinical Trial
35%
Spectral Domain Optical Coherence Tomography
35%
Autosomal Dominant Inheritance
32%
Corneal Transplantation
30%
Image Quality
27%
Endostatin
24%
Lentivirus Vector
24%
Diabetic Retinopathy
24%
Angiostatin
24%
Retinoschisis
21%
Branch Retinal Artery Occlusion
21%
Ganglion Cell Layer
21%
Genotype Phenotype Correlation
21%
Engineered Tissue
21%
Biological Therapy
21%
Keratitis
21%
Biological Marker
21%
Familial Exudative Vitreoretinopathy
21%
Retina Blood Flow
21%
Chorioretinopathy
21%
Microcephaly
21%
Alstrom Syndrome
21%
Adverse Event
16%
Visual Field
15%
Vision
15%
Agents Acting on the Eye
14%
Central Retinal Artery Occlusion
13%
Disease Exacerbation
11%
Ulcer
10%
Photograph
10%
Autofluorescence
10%
Outer Nuclear Layer
10%
Ocular Hypertension
10%
Subretinal Drug Administration
10%
Visual Acuity
10%
Eyelid
10%
Ophthalmoscopy
10%
Retinal Pigment Epithelium
10%
Drug Megadose
10%
Function Test
10%
Carbonate Dehydratase Inhibitor
10%
Transplantation
10%
Keyphrases
Achromatopsia
21%
Lentiviral Vector
21%
Longitudinal Assessment
21%
Neovascularization
21%
Ganglion Cell-inner Plexiform Layer (GC-IPL)
21%
Angiostatin
21%
Repeatability
21%
Endostatin
21%
Cone Structure
21%
Equine Infectious Anemia Virus
21%
Branch Retinal Vein Occlusion
21%
Donor Cornea
21%
Alström Syndrome
21%
CNGB3
21%
Focused Assessment with Sonography for Trauma
21%
Central Retinal Artery Occlusion
13%
KIF11
12%
Hemoperitoneum
12%
Trauma Patients
12%
Corneal Graft Rejection
10%
Macular Flecks
10%
Total Electric Field
10%
Optical Coherence Tomography
9%
Corneal Tissue
8%
Corneal Transplantation
8%
Success Rate
8%
Cornea
8%
Calpain Inhibitor
8%
Clinical Trials
8%
Ganglion Cell Complex Thickness
8%
Measurability
7%
Cone Density
7%
Outer nuclear Layer Thickness
7%
Structural Test
7%
Dyschromatopsia
7%
ALMS1 Gene
7%
Late-onset Hearing Loss
7%
Thickness Change
5%
Toxicological Findings
5%
First-in-human Trials
5%
Proteolysis
5%
Structure Test
5%
Reading Speed
5%
Normal Reading
5%
Number of Patients
5%
Stargardt Dystrophy
5%